VVV

VECTUS BIOSYSTEMS LIMITED

No trades
See on Supercharts
Market capitalization
‪12.77 M‬AUD
−0.045AUD
‪−3.45 M‬AUD
Beta (1Y)
0.23

About VECTUS BIOSYSTEMS LIMITED

CEO
Karen Duggan
Headquarters
North Ryde
Founded
2005
ISIN
AU000000VBS9
FIGI
BBG00BJMG589
Vectus Biosystems Ltd. is a drug discovery and development company, which engages in the treatment for fibrosis and high blood pressure, which includes therapeutics for diseases in the fibrotic market namely heart, kidney, and liver disease. Its lead compounds include VB0004, VB4-A32, VB4-A79, and VB4-P5. The company was founded by Karen Duggan on December 12, 2005 and is headquartered in North Ryde, Australia.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of VBS is 0.275 AUD — it has increased by 14.58% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange VECTUS BIOSYSTEMS LIMITED stocks are traded under the ticker VBS.
VBS stock is 14.00% volatile and has beta coefficient of 0.23. Check out the list of the most volatile stocks — is VECTUS BIOSYSTEMS LIMITED there?
Yes, you can track VECTUS BIOSYSTEMS LIMITED financials in yearly and quarterly reports right on TradingView.
VBS stock has risen by 7.84% compared to the previous week, the month change is a 6.78% fall, over the last year VECTUS BIOSYSTEMS LIMITED has showed a 48.11% decrease.
VBS net income for the last quarter is ‪−1.18 M‬ AUD, while the quarter before that showed ‪−1.31 M‬ AUD of net income which accounts for 10.07% change. Track more VECTUS BIOSYSTEMS LIMITED financial stats to get the full picture.
Today VECTUS BIOSYSTEMS LIMITED has the market capitalization of ‪12.77 M‬, it has decreased by 11.11% over the last week.
No, VBS doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, VBS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade VECTUS BIOSYSTEMS LIMITED stock right from TradingView charts — choose your broker and connect to your account.
VBS reached its all-time high on Oct 19, 2021 with the price of 2.200 AUD, and its all-time low was 0.200 AUD and was reached on Mar 1, 2024.
See other stocks reaching their highest and lowest prices.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So VECTUS BIOSYSTEMS LIMITED technincal analysis shows the buy rating today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating VECTUS BIOSYSTEMS LIMITED stock shows the sell signal. See more of VECTUS BIOSYSTEMS LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.